PMN

PMN

USD

ProMIS Neurosciences Inc. Common Shares (ON)

$0.406-0.004 (-0.878%)

Real-time Price

Healthcare
Biotechnology
Canada

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$0.410

High

$0.419

Low

$0.401

Volume

0.28M

Company Fundamentals

Market Cap

21.9M

Industry

Biotechnology

Country

Canada

Trading Stats

Avg Volume

1.51M

Exchange

NCM

Currency

USD

52-Week Range

Low $0.38Current $0.406High $1.59

Related News

GlobeNewswire

ProMIS Neurosciences to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference

Cambridge, Massachusetts, Nov. 03, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (NASDAQ:PMN), a clinical-stage biotechnology company developing next-generation therapies for Alzheimer's disease (AD) and other

View more
ProMIS Neurosciences to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference
GlobeNewswire

ProMIS Neurosciences Strengthens Board with Appointment of Slanix Paul Alex, Pharm.D., President and Portfolio Manager, Public Equity of Ally Bridge Group

Appointment reinforces ProMIS Neurosciences' strategic vision and deepens investor engagement as the Company advances its differentiated Alzheimer's program, PMN310 Cambridge, Massachusetts, Oct. 22, 2025 (GLOBE

View more
ProMIS Neurosciences Strengthens Board with Appointment of Slanix Paul Alex, Pharm.D., President and Portfolio Manager, Public Equity of Ally Bridge Group